Editorial: vaccination against an oncogenic herpesvirus.
D000818:Animals; D000914:Antibodies, Viral / Q000302:isolation & purification; D000882:Haplorhini; D006564:Herpesviridae / Q000276:immunology*; D006566:Herpesviridae Infections / Q000517:prevention & control*; D006801:Humans; D007110:Immunity, Active; D008223:Lymphoma / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D009369:Neoplasms / Q000209:etiology / Q000517:prevention & control*; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use
D000914:Antibodies, Viral; D014765:Viral Vaccines